MOMA Therapeutics
Cambridge, United States· Est.
Is this your company? Claim your profile to update info and connect with investors.
Claim profilePrivate Company
Total funding raised: $600M
Overview
Targeting cancer's essential molecular machines (ATPases) with small molecule therapeutics.
Oncology
Technology Platform
The KnowledgeBase platform integrates multiple disciplines to identify and drug cancer dependencies related to ATPase molecular machines.
Funding History
4Total raised:$600M
Series E$150M
Series D$150M
Series C$150M
Series B$150M
Opportunities
Potential to unlock a major new class of oncology targets, leading to first-in-class therapies for multiple cancers.
Risk Factors
High scientific risk in drugging complex molecular machines and validating a novel mechanism in the clinic.
Competitive Landscape
A pioneer in targeting ATPases; faces future competition from other companies exploring molecular machines and allosteric inhibition.